Minor
TIL Injection · Metastatic or Recurrent Solid Tumors
Enrollment closed, study ongoing
Grit BiotechnologyPhase 1 NCT06088472 Registry history of NCT06088472 on ClinicalTrials.gov (opens the registry)
Updated
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Enrollment closed, study ongoing
Grit BiotechnologyPhase 1 NCT06088472 Registry history of NCT06088472 on ClinicalTrials.gov (opens the registry)
Updated
| Early Phase 1 | 8 | |
| Phase 1 | 4 | |
| Phase 1/2 | 2 | |
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06241781 | Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or… | Adult | Recruiting | 2026-04-15 |
| Phase 1/2 | ||||
| NCT06948981 | GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell… | Hematological Malignancy (Leukemia- Lymphoma) | Recruiting | 2026-09-18 |
| NCT06144671 | Phase I/II Clinical Study of GT201 Injection as Monotherapy or in Combination With PD-1… | Advanced Solid Tumors | Recruiting | 2026-08-19 |
| Phase 1 | ||||
| NCT05430373 | GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors | Solid Tumors, Adult | Recruiting | 2026-09-14 |
| NCT07021209 | GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases | Neurological Autoimmune Diseases | Recruiting | 2026-09-11 |
| NCT06819293 | IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma | Advanced Clear Renal Cell Carcinoma | Recruiting | 2026-04-14 |
| NCT06088472 | TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors | Solid Tumors, Adult | Active, Not Recruiting | 2026-09-18 |
| Early Phase 1 | ||||
| NCT07122076 | GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases | Autoimmune Diseases | Recruiting | 2026-09-18 |
| NCT07205315 | A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients… | B-cell Acute Lymphoblastic Leukemia (B-ALL) | Recruiting | 2026-07-20 |
| NCT07333118 | A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment… | Moderate to Severe Refractory Autoimmune Disease | Recruiting | 2026-05-27 |
| NCT07132112 | GT719 Injection for Moderate to Severe Refractory Autoimmune Disease | Auto Immune Disease | Recruiting | 2026-04-16 |
| NCT07253259 | A Clinical Study Evaluating the Safety and Efficacy of GT729 Universal Cell Injection in… | cGVHD | Recruiting | 2026-04-14 |
| NCT07131254 | A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in… | Hematological Malignancy (Leukemia- Lymphoma) | Recruiting | 2025-12-30 |
| NCT07389499 | A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in… | IgA Nephropathy (IgAN) | Not Yet Recruiting | 2026-09-11 |
| NCT07676006 | A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell… | Relapsed/Refractory Acute Myeloid Leukemia (AML) | Not Yet Recruiting | 2026-09-11 |
| Not applicable | ||||
| NCT06190275 | Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck… | HNSCC | Recruiting | 2026-04-24 |
| NCT06453057 | Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid… | Adult | Recruiting | 2026-04-14 |
| NCT06819280 | Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Advanced… | Adult | Recruiting | 2026-04-14 |
| NCT06397963 | Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients… | Solid Tumor, Adult | Recruiting | 2026-01-26 |
Leukemia (4) · Acute Lymphoblastic Leukemia (ALL) (1) · Acute Myeloid Leukemia (AML) (1) · Chronic Lymphocytic Leukemia (CLL) (1) · Head & Neck Cancer (1) · Kidney Cancer (1) · Non-Hodgkin Lymphoma (1)